GRP78 levels are reported to be upregulated in GBM specimens when compared to control brains, low-grade astrocytomas, and oligodendrogliomas, and elevated GRP78 expression is significantly correlated with poor patient survival [25–27]. This evidence concerns the gene HSPA5 and glioblastoma.